2016 American Transplant Congress
Living Donor Liver Transplantation for Children With Biliary Atresia in the Pediatric End-Stage Liver Disease Era: The Role of Age and Insurance Status.
Lower socioeconomic status has been linked to inferior health outcomes. We have previously shown that children with biliary atresia (BA) who have public insurance (PU)…2016 American Transplant Congress
Use of the Psychosocial Assessment Tool to Identify Risk in Families of Pediatric Liver Transplant Recipients.
Pediatrics, University of Michigan, Ann Arbor, MI.
Purpose: Although families of pediatric liver transplant recipients have documented psychosocial needs, the systematic identification of needs and delivery of evidence-based care remain challenging. This…2016 American Transplant Congress
Liver Transplantation for Propionic Acidemia: A Review of the United States Scientific Registry for Transplant Recipients (SRTR) and Non-US Case Series.
Surgery, Childrens Hospital of Pgh, Pittsburgh.
Background: A fifth of all pediatric liver transplants in the US are performed for metabolic disease. Propionic acidemia, an autosomal recessive branched chain organic acidemia…2016 American Transplant Congress
The Effect of Maternal Graft in Early Acute Cellular Rejection After Pediatric Living Donor Liver Transplantation.
Objectives: It has been reported that the living donor liver transplantation (LDLT) in which the patients received a maternal graft could be more successful compared…2016 American Transplant Congress
Outcome of Partial Reconstruction of Multiple Hepatic Arteries in Pediatric Living Donor Liver Transplantation Using Left Lateral Section Grafts.
In pediatric end-stage liver disease patients, the use of partial liver grafts from adult living donors has been increasing for liver transplantation due to a…2016 American Transplant Congress
The Impact of Thromboelastography on Resuscitation in Pediatric Liver Transplantation.
Introduction: Thromboelastography (TEG) directs effective resuscitation in adult surgical and trauma patients. There is little data on TEG use in pediatrics. In 2011 we began…2016 American Transplant Congress
Conversion from Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma – 2 Year Follow-Up.
Introduction: The appropriate use of Sirolimus (SRL) immunosuppression in pediatric liver transplantation has yet to be clearly defined. Even though Tacrolimus (TAC) is commonly used…2016 American Transplant Congress
Mass Cytometry Reveals NK Cell and T Cell Subsets in Pediatric Liver Transplant Patients with Acute Rejection.
1Pediatrics, Stanford/LPCH, Palo Alto, CA; 2Surgery, Stanford, Palo Alto, CA.
Proper evaluation of the immune status of liver transplant recipients is crucial for appropriate post-transplant management. Current monitoring of graft function relies mainly on non-specific…2016 American Transplant Congress
Growth of Liver Allografts in Pediatric Transplant Recipients.
Columbia University Medical Center, New York, NY.
IntroductionThe liver's capacity to grow in response to metabolic need is well known. However, the long-term growth of liver allografts transplanted in pediatric patients has…2016 American Transplant Congress
Factors in a Successful Transfer of Pediatric Liver Transplant Recipients to Adult-Based Care.
University of Michigan, Ann Arbor.
Purpose: A structured shift in allocation of responsibility (AoR) for health-management tasks from parents to adolescents is an important component of the transfer to adult-based…
American Transplant Congress abstracts